Abstract
Ionis Pharmaceuticals and Akcea Therapeutics have developed inotersen (Tegsedi), an antisense oligonucleotide inhibitor of mutant and wild-type human ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
